Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

MGI Pharma expands prostate cancer study with MGI-114

Dec. 10, 1998

Techniclone initiates phase II trial for treatment of malignant glioma

Dec. 9, 1998

CMA-676 shows efficacy and excellent tolerability in patients with AML

Dec. 9, 1998

Excellent results obtained in AML patients receiving Maxamine plus IL-2

Dec. 9, 1998

U.S. patent covers Coulter's antibody therapy for B-cell lymphoma

Dec. 9, 1998

Biomira initiates pivotal phase III trial of Theratope vaccine

Dec. 7, 1998

Maxamine Therapy enters phase II trial for late-stage RCC

Dec. 4, 1998

Coulter and SB enter agreement to develop and commercialize I-131 anti-B1 antibody

Dec. 4, 1998

Enrollment completed in phase I Biomira lung cancer vaccine trial

Dec. 4, 1998

MDX-210 demonstrates antitumor activity in phase II studies

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...